Ingalls & Snyder LLC Grows Position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Ingalls & Snyder LLC lifted its stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 13.6% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 338,779 shares of the pharmacy operator’s stock after buying an additional 40,570 shares during the quarter. Ingalls & Snyder LLC’s holdings in Walgreens Boots Alliance were worth $3,161,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of WBA. Mill Creek Capital Advisors LLC bought a new position in shares of Walgreens Boots Alliance in the fourth quarter worth about $184,000. International Private Wealth Advisors LLC raised its position in shares of Walgreens Boots Alliance by 14.5% in the 4th quarter. International Private Wealth Advisors LLC now owns 14,730 shares of the pharmacy operator’s stock valued at $137,000 after purchasing an additional 1,870 shares during the last quarter. Newbridge Financial Services Group Inc. purchased a new position in shares of Walgreens Boots Alliance in the 4th quarter valued at approximately $184,000. Empowered Funds LLC increased its holdings in Walgreens Boots Alliance by 16.5% in the 4th quarter. Empowered Funds LLC now owns 26,084 shares of the pharmacy operator’s stock worth $243,000 after buying an additional 3,685 shares during the period. Finally, Cidel Asset Management Inc. increased its holdings in Walgreens Boots Alliance by 29.8% in the 4th quarter. Cidel Asset Management Inc. now owns 61,847 shares of the pharmacy operator’s stock worth $577,000 after buying an additional 14,191 shares during the period. Institutional investors own 58.59% of the company’s stock.

Wall Street Analyst Weigh In

A number of brokerages have recently commented on WBA. Evercore ISI raised their price objective on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock an “in-line” rating in a research note on Monday, January 13th. Jefferies Financial Group decreased their target price on Walgreens Boots Alliance from $19.00 to $9.00 and set a “hold” rating on the stock in a research report on Wednesday, October 23rd. Bank of America increased their target price on Walgreens Boots Alliance from $7.50 to $8.50 and gave the company an “underperform” rating in a research report on Monday, January 13th. Truist Financial decreased their price objective on Walgreens Boots Alliance from $13.00 to $12.00 and set a “hold” rating on the stock in a report on Friday, January 31st. Finally, Royal Bank of Canada raised their price objective on Walgreens Boots Alliance from $9.00 to $12.00 and gave the company a “sector perform” rating in a report on Wednesday, January 15th. Four investment analysts have rated the stock with a sell rating, nine have given a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat, Walgreens Boots Alliance presently has a consensus rating of “Hold” and an average target price of $13.19.

Walgreens Boots Alliance Stock Performance

Walgreens Boots Alliance stock opened at $9.47 on Thursday. Walgreens Boots Alliance, Inc. has a 12 month low of $8.08 and a 12 month high of $22.55. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.30 and a current ratio of 0.64. The business has a 50 day simple moving average of $10.25 and a 200-day simple moving average of $9.77.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings data on Friday, January 10th. The pharmacy operator reported $0.51 EPS for the quarter, beating analysts’ consensus estimates of $0.38 by $0.13. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. The business had revenue of $39.50 billion for the quarter, compared to analyst estimates of $37.40 billion. During the same quarter last year, the company earned $0.66 earnings per share. The business’s revenue for the quarter was up 7.6% compared to the same quarter last year. Equities research analysts anticipate that Walgreens Boots Alliance, Inc. will post 1.6 EPS for the current year.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.